The Business Research Company’s Flow Cytometry In Oncology And Immunology Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Flow Cytometry In Oncology And Immunology Global Market Report 2023 evaluates flow cytometry in oncology and immunology market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12469&type=smp
The global flow cytometry in oncology and immunology market is expected to grow from $1.70 billion in 2022 to $1.89 billion in 2023 at a compound annual growth rate (CAGR) of 11.03%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The flow cytometry in oncology and immunology market is expected to reach $2.79 billion in 2027 at a CAGR of 10.2%.
The increasing prevalence of cancer is expected to propel the growth of flow cytometry in the oncology and immunology markets going forward. Cancer is a disease to describe a group of disorders characterized by the uncontrolled growth and spread of abnormal cells in the body. Flow cytometry is a widely used technique in oncology and immunology for studying cancer and immune cells. For instance, in October 2022, in Macmillan Cancer Support, a UK-based healthcare charity organization, 3 million people had cancer in 2020, and it is estimated that it will rise to 3.5 million by 2025 and 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer is driving the growth of flow cytometry in the oncology and immunology markets.
Get More Information On The Flow Cytometry In Oncology And Immunology Market Report:
The flow cytometry in oncology and immunology market segments in the report are:
1) Flow Cytometry In Oncology And Immunology Market By Type: Immunology, Oncology
2) Flow Cytometry In Oncology And Immunology Market By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) Flow Cytometry In Oncology And Immunology Market By Application: Translational Research, Clinical Research
4) Flow Cytometry In Oncology And Immunology Market By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Top Major Players
The table of contents in TBRC’s flow cytometry in oncology and immunology market report includes:
1. Executive Summary
2. Flow Cytometry In Oncology And Immunology Market Characteristics
3. Flow Cytometry In Oncology And Immunology Market Trends And Strategies
4. Flow Cytometry In Oncology And Immunology Market – Macro Economic Scenario
……
32. Global Flow Cytometry In Oncology And Immunology Market Competitive Benchmarking
33. Global Flow Cytometry In Oncology And Immunology Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Flow Cytometry In Oncology And Immunology Market
35. Flow Cytometry In Oncology And Immunology Market Future Outlook and Potential Analysis
36. Appendix
List Of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
……
Table 75: Thermo Fisher Scientific Inc. Financial Performance
Table 76: Danaher Corporation Financial Performance
Table 77: Merck KGaA Financial Performance
Table 78: Becton Dickinson and Company Financial Performance
Table 79: Laboratory Corporation of America Holdings Financial Performance
Read Related Reports:
https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report
https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report
https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
